| Product NDC: | 51285-138 |
| Proprietary Name: | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
| Non Proprietary Name: | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
| Active Ingredient(s): | & nbsp; Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51285-138 |
| Labeler Name: | Teva Women's Health, Inc. |
| Product Type: | VACCINE |
| FDA Application Number: | BLA125296 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20110531 |
| Package NDC: | 51285-138-50 |
| Package Description: | 1 KIT in 1 CARTON (51285-138-50) * 100 TABLET, COATED in 1 BOTTLE (51285-174-02) * 100 TABLET, COATED in 1 BOTTLE (51285-175-02) |
| NDC Code | 51285-138-50 |
| Proprietary Name | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
| Package Description | 1 KIT in 1 CARTON (51285-138-50) * 100 TABLET, COATED in 1 BOTTLE (51285-174-02) * 100 TABLET, COATED in 1 BOTTLE (51285-175-02) |
| Product NDC | 51285-138 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20110531 |
| Marketing Category Name | BLA |
| Labeler Name | Teva Women's Health, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |